Navigation Links
Amgen To Present At The Baird Healthcare Conference
Date:8/31/2012

THOUSAND OAKS, Calif., Aug. 31, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will participate in the Baird Healthcare Conference on Thursday, Sept. 6, 2012, at The New York Palace Hotel in New York City, beginning at 1:24 p.m. Eastern Daylight Time. Arvind Sood, vice president of Investor Relations at Amgen, will present. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit www.amgen.com.  Follow us on www.twitter.com/amgen.


CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Eric Hylengren, 805-447-1060 (investors)

(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
2. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
3. Amgen Completes Acquisition of KAI Pharmaceuticals
4. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
5. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
6. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
7. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
8. Amgen to Present at the Baird Growth Stock Conference
9. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
10. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
11. Sigma-Aldrich Corporation To Present At Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... 17, 2017 Research and Markets has announced the ... to their offering. ... report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , Latin America , and Rest ... through 2022. Also, a six-year historic analysis is provided for these markets. ...
(Date:2/17/2017)... 17, 2017 Arvinas LLC, a private biotechnology ... protein degradation, today announced the presentation of new preclinical ... a poster session at the American Society of Clinical ... Orlando, FL. "The ... and the potential of PROTACs to drive durable and ...
(Date:2/17/2017)... , Feb. 17, 2017   Risperdal lawsuits involving ... allegedly associated with use of the atypical antipsychotic medication ... Court of Common Pleas, where the state,s ... program. According to a notice posted on the ... a meeting on March 9, 2017 at 11:00 a.m. ...
Breaking Medicine Technology:
(Date:2/19/2017)... (PRWEB) , ... February 19, 2017 , ... ... proven to result in better care, and MEDfx and the Delaware Health Information ... of Delaware. , As the nation’s first state-wide health information exchange, DHIN stores ...
(Date:2/18/2017)... , ... February 17, 2017 ... ... for Devicemakers , Sponsored by Axendia, **FDAnews Free Webinar**, March 1, 2017 ... manufacturers looking to reduce their regulatory burden? Pay dividends in enhanced and ...
(Date:2/18/2017)... Lewisberry, PA (PRWEB) , ... February 17, 2017 , ... ... more about the Stannah Stairlift and other Butler products. Ken was impressed with ... team, and agreed to endorse the product on his show. This endorsement by ...
(Date:2/18/2017)... ... ... Park Cities Pet Sitter President, Joette White, has been featured on Episode 304 ... episode, which was posted this week, features a 30-minute interview of White by Moore ... Sitter’s being awarded the 2017 National Association of Professional Pet Sitter’s Business of the ...
(Date:2/18/2017)... ... February 18, 2017 , ... ... the latest information and contact points to easily connect elderly veterans of America's ... living, and elder-care funding. It also conveys material on this year's increase in ...
Breaking Medicine News(10 mins):